Double-blind randomized controlled clinical-trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (vol 54, pg 2817, 2006) (ARTHRITIS AND RHEUMATISM, 2008)

(untitled) - Maini, R; Taylor, P; Szechinski, J; Pavelka, K; Broll, J; Balint, G; Emery, P; Raemen, F; Petersen, J; Smolen, J; Thomson, D; Kishimoto, T